Bloodstream infections due to Candida species in the intensive care unit: identifying especially high-risk patients to determine prevention strategies

scientific article

Bloodstream infections due to Candida species in the intensive care unit: identifying especially high-risk patients to determine prevention strategies is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1086/430923
P698PubMed publication ID16108005
P5875ResearchGate publication ID7652670

P2093author name stringRichard P Wenzel
Chris Gennings
P2860cites workDouble-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patientsQ28362691
Choice of effect measure for epidemiological dataQ30614196
Epidemiology of Candida species infections in critically ill non-immunosuppressed patientsQ34273626
The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU settingQ34509624
Attributable mortality of nosocomial candidemia, revisitedQ44386169
Nosocomial bloodstream infections in United States hospitals: a three-year analysisQ44863798
Perspective: Attributable mortality--the promise of better antimicrobial therapyQ45113430
Etiologic organisms as independent predictors of death and morbidity associated with bloodstream infectionsQ45259096
P407language of work or nameEnglishQ1860
P921main subjectpatientQ181600
intensive care unitQ5094647
P304page(s)S389-93
P577publication date2005-09-01
P1433published inClinical Infectious DiseasesQ5133764
P1476titleBloodstream infections due to Candida species in the intensive care unit: identifying especially high-risk patients to determine prevention strategies
P478volume41 Suppl 6